Premium
How to preserve potency and continence in localized prostate cancer
Author(s) -
Breda Guglielmo,
Celia Antonio
Publication year - 2007
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/j.1464-410x.2007.06950.x
Subject(s) - potency , prostate cancer , medicine , urinary continence , prostate , urology , cancer , biology , prostatectomy , biochemistry , in vitro
Recent data show that, at 10 years of followup, overall and cancer-specific survival after RT, whether it be external beam RT (EBRT), intensity-modulated RT, brachytherapy (also called interstitial RT), or brachytherapy plus EBRT, are similar to those achieved after radical prostatectomy (RP) [5]. However, the incidence of erectile dysfunction is 43–62% at 3 years after RT [6], and pain on orgasm and haematospermia caused by brachytherapy can also affect sexual function [7]. Therefore RT does not appear to achieve the trifecta.